Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Guanine nucleotide-binding protein subunit beta-4 (GNB4) is a protein coding gene that encodes the beta subunit of heterotrimeric G proteins. These proteins are membrane-bound GTPases that integrate signals between cell surface receptors (especially G protein-coupled receptors) and effector proteins, playing essential roles in transmembrane signaling. The beta subunit regulates the activity of alpha subunits and modulates signal transduction through interaction with receptors and effectors. Mutations in GNB4 have been linked to inherited neurological disorders such as Charcot-Marie-Tooth disease and have also been implicated in cancer progression. The beta subunit acts in concert with its gamma partner to facilitate receptor-triggered GDP–GTP exchange and downstream signaling events.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanine nucleotide-binding protein subunit beta-4 (GNB4).